ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Bears Pile Into Lucid and Chewy as GME Shorts Flee

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Short sellers made bold moves this week. Two names stand out as big movers, while GameStop's shorts ran for the exits.

LCID leads the charge. Lucid Group's short interest jumped 14.4 percentage points in just seven days. It now sits at 49.7% of free float. Availability is razor thin at just 0.4% of SI. That means borrowing shares is nearly impossible for new bears — a classic squeeze setup.

CHWY is equally crowded. Chewy's SI % FF surged 13.8 points to 77.7%. Bears are heavily positioned ahead of earnings season. The stock is down on worries about pet spending cutbacks in an inflationary environment.

WOLF is getting crushed. Wolfspeed sits at 83% short interest. That jumped another 7.7 points this week. The semiconductor firm has struggled with losses and debt concerns. Cost to borrow remains cheap at 2.4% — shorts aren't yet squeezed.

GameStop's bears bailed. GME saw its SI % FF collapse from 9% to under 1% in a week. That is a massive short cover. Social media buzz around GME picked up sharply this week, possibly triggering the exit.

SCTX is a new entrant. Scribe Therapeutics jumped from 4.1% to 11.2% short interest this week. The CRISPR-focused biotech drew fresh bearish attention as gene editing valuations face scrutiny.

Not financial advice. Data sourced from ORTEX as of September 10, 2026.

Stocks in this article

How this article was generated

Generated
14 Sept 2026, 00:06
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilization

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.